The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.
The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.
Key Challenges
Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.
Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.
“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”
Opportunities
The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.
Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:
Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.
Conclusion
The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.
Bone marrow is a soft vascular tissue present in the interior of long bones. It consists of two types of stem cells: hematopoietic and mesenchymal stem cells. Bone marrow is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes,... View more
Personalized Cell Therapy Market - Insights Individualized treatment for various diseases such as cancer and autoimmune diseases by injecting living cells into a patient’s body is known as personalized cell th... View more
B-Cell Maturation Antigen (BCMA) Targeted Therapy – An innovative therapy for multiple myeloma Multiple myeloma (MM) refers to a clonal plasma cell malignant neoplasm that is observed in the soft, spong... View more
Human microbiome plays a major role in modern healthcare as they have multiple functions such as, enabling easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12. Human microbiome boosts immunity, ... View more
Cancer Biomarkers Market – Insights Cancer biomarkers are biological molecule produced either by tumor cells or by human tissues in response to cancer, which then measured and evaluated as an indicator ... View more
Next Generation Sequencing Market – Sequencing Made Easy Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that is used in several areas of biological study. NG... View more
Digital Genome Market - Insights Digital genome is one of the emerging technologies in DNA sequencing, which allows to perform human genome sequencing and digitalization in minutes and at the cost of only a f... View more
Cell Culture Market-Breakthrough in Breast Cancer Diagnosis Cell culture is fast emerging as an important tool for treatment and diagnosing chronic diseases. Companies are focusing on diversifying their cel... View more
Redesigning organisms for useful purposes by engineering them to have new abilities is known as synthetic biology. It involves the multidisciplinary area of research that seeks to create new biological parts, devices, and systems or to redesign systems that are alread... View more
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells. CAR T-cell therapy is helps to treat some kinds of lymphomas and leukemias, as well as multiple myeloma. Many clinical trial studies conducted globally for CAR T-cell therapies... View more
Vocal Biomarkers Market – Insights Sound vibrations are used in therapeutic healing for mental health conditions such as depression and anxiety. Recent research has broadened its application for diagnos... View more
Artificial Pancreas Device System (APDS) Market- Insights Administering insulin on a daily basis can be cumbersome for type 1 diabetes (T1D) patients. Devices such as insulin pumps, pens, and jet injectors ha... View more
Tooth Regeneration Global dental industry has undergone a drastic transformation over the last decade. Teeth are among the most important part of human beings, which helps in performing various activities ran... View more
Dengue Vaccine Market – Insights Dengue fever, also known as breakbone fever, is a mosquito-borne viral infection causing a severe flu-like illness. The condition can lead to a potentially lethal complicati... View more
Biopharmaceutical and Biomedicine Market - Insights Biopharmaceuticals are drugs that are partially or fully manufactured, or extracted from biological sources. Biopharmaceuticals contain variety of products ... View more
Contact Us